We're securing early pharma access for ApoE4 carriers, and more! (join before pricing changes)

Hi Phoenix Friends,

In August, we crossed a critical threshold for our ApoE4 members.

We're now in active discussions with multiple pharma companies to secure early access to innovative therapies specifically for ApoE4 carriers—through clinical trials, early patient access programs, and other initiatives. When these programs launch, Phoenix members get cutting-edge therapies before they hit the market.

Time is of the essence.
The earlier we act, the better the results.
That's why leveraging our collective power is one of our core focus.

We're building two pathways to earlier interventions:

1. Early pharma access programs - First access to therapies with strong ApoE4 signals

2. Subsidized med-tech partnerships - We've secured heavily discounted pricing on medical devices in exchange for anonymized usage data and outcomes (cognition tests, blood markers, etc.). The medtech companies get real-world evidence. You get interventions at a fraction of the cost.

More partnerships details coming in the next newsletter once we finalize the details.

The Win-Win Structure We've Built: 
Healthcare companies get real-world outcomes data, proof their solutions work, and patient advocacy.
You get interventions that could change your trajectory—earlier and cheaper than waiting years (or decades!) for general availability.

While we build these game-changing partnerships, our community is already delivering value every day.

In August alone, Phoenix members engaged in 80+ discussions on interventions, protocols, and strategies specific to ApoE4 carriers.
Carriers like you, sharing real results in real-time.

We are not a waiting room for future therapies: we are an active laboratory where members are testing, tracking, and sharing what works right now.
See the full list of topics at the end of this email.

This is your last call for Founding Member status.

Once we launch the Phoenix Experiment module (leveraging AI, big data, and digital twin technology to match you with interventions that work for people with your exact health profile), our pricing changes permanently.
The recurring costs of running these AI models force us to switch to a subscription model. There's no way around it.

• Join now as a Founding Member: $499 one-time for LIFETIME access

• Join after launch: $499 every year.

The door closes when the Phoenix Experiment module goes live.

Secure Your Lifetime Access for $499 →

Make your move.
If you have any questions, just reply to this email. I reply personally to each one of them.

P.S. The partner discounts we're negotiating could reimburse your lifetime membership with just one subsidized intervention. We're building a portfolio of these partnerships: blood tests, diagnostics, med-tech, pharma, and more.
The math is simple.
The decision should be too.

What you missed in The Phoenix Community in August

Quick summary of the most popular topics discussed this past month:

• ALZ-801, vaccines, and lifestyle trials keep adding signal. This shapes real options you can act on.

• Lipids stay center stage. Threads on ApoB, ezetimibe, DHA forms, rapamycin, and statins help you choose and track.

• Fitness and sleep posts show clear wins. VO2 up, deep rest tools in play, and a new suvorexant discussion.

• Biomarkers got practical. Ptau217 access and costs, direct-access menus by state, and real member data.

• Genetics nuance grew. Protective variants and ancestry modifiers point to more precise plans.

All discussions by Space:

🧬 Research

• Latest on ALZ-801 trial

• Large POINTER study finds cognitive improvements with intensive structured lifestyle changes

• We have to put this controversy to rest once and for all
  AD clinical studies

• What I learned from Rhonda Patrick’s analysis

• APOE4: Scientists reversed memory loss + found social factors override genetics

• APOE ε4 carriers share immune-related proteomic changes

• New ApoE4 Science About Estrogen and Brain Health!

• Reevaluating the role of education on cognitive decline

• Vaccines and dementia Huge study showing benefits of two common vaccines, Shingles and RSV Varicose veins and dementia

• ApoE4 & Alzheimer’s: 11 New Discoveries That Changed My Game Plan

• ApoE4? New Brain Protection Breakthroughs Every Carrier Must See
  (Small) study says intense lifestyle changes can not only stop but even reverse Alzheimer’s

• Handgrip study

💊 Supplements, Nutrition, and Medication

• How to lower APOB

• Interesting article from Peter Attia on inducing ketosis

• Small human pilot study shows 20 g creatine supplementation improved brain energetics

• Ezetimibe for prevention

• What oil do you use for cooking?

• Could Statins Be Our Secret Weapon Against Dementia?

• Update on Lipids after 90 days on statin and ezetimibe

• Online Source for peptides

• These Omega-3s, they smell fishy…

• Next Intervention – Rapamycin

• Phospholipid-form DHA – what do you use?

• Methylene Blue?

• Choline (Alpha GPC), big “no regret” supplement

• I Have Stopped Taking Ezetimibe

• My view about keto: not adapted when doing 12h+ of sport per week

• Has anyone used Saffron?

• Microdosing Semiglutide

• Nut Pods Y or N

• Protein Bars

• LPC-DHA (Lysoveta)

• Dairy fat, Cheese, Cream.. Are they all equally bad for LDL-C?

• Cholesterol medication?

• Ursolic acid

• Quality control on Supplement brands

• Psyllium husk – For fiber and tactical use to blunt absorption

• Is Alcohol good or bad for you? In moderation or not at all?

• Anyone with experience with Kisunla (donanemad-azbt)?

• Modified Citrus Pectin (MCP) and stress reduction

• What do you do to keep lipids under control?

🏃 Sports, Sleep, and Stress Management

• Suvorexant

• Finally focusing on VO2 Max / Zone 4/5 Training

• Sleep Optimization Sleep Trackers Research & More, Matthew Walker Interview

• What sports / activities do you do?

• Neuroplasticity Thread

• Sleep optimization with mouth taping

• Outsized effect interventions for brain clarity / avoiding brain fog

• Factors affecting sleep – mystified

• NSDR – Non Sleep Deep Rest

🔬 Biomarkers, Tracking, Monitoring

• Lipoprotein(a) (Lp(a))

• Cost of beta amyloid 40/42 and p-tau217 tests

• Klotho may really help..

• Obicetrapib – Delayed Progression p-Tau217

• Any experience with Care Access screenings?

• Direct-Access Testing by U.S. State

• Cholesterol Balance Test Hyper absorb or Hyper produce

• Anyone tried Dr Goodenowe’s ProdromeScan?

• Increase in T-p-tau181

• PET scan results indicate BAPL3, indicating substantial plaque build up

🧠 Mental Health & Emotional Resilience

• You’re not alone — this space is for the emotional side of the journey

• URGH! I’m overwhelmed and burnt out.

• When I found out I had APOE4/4, my brain played tricks on me

💻 Tech and Medical Devices

• Brain Health Dosing with Red Light Therapy

• Red Light Therapy

• Wearables

🧬 Genetics

• My Genetics

• 3X4 Genetics – Memory and Brain Health Snps

• Your Ancestry Changes How ApoE4 Works: 3 Breakthroughs

• Deep dive into 3 protective APOE variants that block Alzheimer’s

📢 Announcements

• Your Phoenix Monthly Check-In Just Got Smarter (And Way More Personal)

• Shape the Ultimate Personalized APOE4 Protocol: Decide Which Features Matter to You!

🎁 Perks and Partnerships

• Whole Genome Sequencing: Nucleus

• Whole Genome Sequencing: Sequencing.com

• Photo biomodulation: Neuronic

🤝 General and Off Topic

• Opening address for Thurs July 31, 2025 at AAIC

• AAIC presentation: The Importance of Early Detection

• Alzheimer’s Association International Conference, Toronto, Canada

• Blacked out 1 week of memory after taking meds for muscle / nerve injury

• Labcorp vs Quest

• Made a Decision on Kisunla Today

• Long Term Care insurance – especially USA

• Advanced Directive (More than Medical!)

• Cure for Alzheimer’s?

If you’d like to join the discussion, apply to join the Phoenix Community here.

Onward,
Kevin